Publications by authors named "Torsten Witte"

Claim this Profile
C
CXCR4-Targeted Imaging in Takayasu Arteritis Using 68 Ga-Pentixafor PET/CT.
Thorsten Derlin, Torsten Witte

Clin Nucl Med· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of LP.8.1-adapted mRNA vaccination on SARS-CoV-2 variant neutralisation.
Christine Happle, Markus Hoffmann, Metodi V Stankov, Inga Nehlmeier, Amy Eichmann, Torsten Witte

Lancet Infect Dis· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[This is how I treat arthritis in Sjögren's syndrome under hydroxychloroquine and methotrexate intolerance].
Torsten Witte

Z Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Patient satisfaction in patients with rheumatoid arthritis : Effects of delegation to rheumatological specialist assistants].
Birte Luise Hägermann, Juliana Rachel Hoeper, Sara Eileen Meyer, Patricia Steffens-Korbanka, Torsten Witte

Z Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLIP2: a novel functional player in AQP5 trafficking dynamics and implications for Sjögren's disease.
Claudia D'Agostino, Nikola Filipovic, Egor Zindy, Louise Conrard, Zhen Wang, Torsten Witte

Cell Commun Signal· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Delegating clinical tasks to medical practice assistants: qualitative analysis of experiences from the DELIVER CARE study].
Kathrin Damm, Juliana Hoeper, Maike Kriependorf, Lukas Noll, Torsten Witte

Z Evid Fortbild Qual Gesundhwes· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-VGLUT2 autoantibodies in neurological diseases.
Merle Corty, Friederike A Arlt, Kathrin Borowski, Stephanie Wernick, Madeleine Scharf, Torsten Witte

Brain Behav Immun· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enpatoran, a first-in-class, selective, orally administered toll-like receptor 7/8 inhibitor, in systemic and cutaneous lupus erythematosus: results from a randomised, placebo-controlled phase Ib study.
Torsten Witte, Ruth Fernandez-Ruiz, Nadezda Abramova, Dominika Weinelt, Flavie Moreau

Lupus Sci Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland.
Mandi M Wiley, Marcin Radziszewski, Bhuwan Khatri, Michelle L Joachims, Kandice L Tessneer, Torsten Witte

Ann Rheum Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications.
Peter C Taylor, Thomas Bieber, Rieke Alten, Torsten Witte, James Galloway

Adv Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A germline IκBα mutation outside the signal reception domain blocks nuclear translocation of NFκB1 and associates with autoinflammation-like features.
Abdulwahab Elsayed, Ignatius Ryan Adriawan, Faranaz Atschekzei, Natalia Dubrowinskaja, Manfred Anim, Torsten Witte

Ann Rheum Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Renewed increase in new Janus kinase inhibitor prescriptions : Analysis of the German RHADAR registry].
Patrick-Pascal Strunz, Linus Maximilian Risser, Matthias Englbrecht, Torsten Witte, Matthias Fröhlich

Z Rheumatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idiopathic inflammatory myopathy associated with Sjögren's disease: features of a distinct clinical entity.
Franz Felix Konen, Yunus Emre Güzeloglu, Tabea Seeliger, Konstantin Fritz Jendretzky, Sandra Nay, Torsten Witte

Front Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cells of patients with systemic sclerosis or Sjögren's disease display an aberrant metabolic state and memory phenotype in blood and lungs.
Christine Ehlers, Hannah Biermann, Thea Thiele, Jonas C Schupp, Matteo Villa, Torsten Witte

Rheumatology (Oxford)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing research on regulatory autoantibodies targeting GPCRs: Insights from the 5th international symposium.
Otavio Cabral-Marques, Lena F Schimke, Guido Moll, Igor Salerno Filgueiras, Adriel Leal Nóbile, Torsten Witte

Autoimmun Rev· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kappa free light chain concentration in serum is reduced after CD20-depletion with ocrelizumab.
Franz Felix Konen, Gudrun Mechthild Körner, Martin W Hümmert, Philipp Sebastian Gehring, Philipp Schwenkenbecher, Torsten Witte

Neurol Res Pract· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel hemizygous nonsense variant in DOCK11 causes systemic inflammation and immunodeficiency.
Abdulwahab Elsayed, Sandra von Hardenberg, Faranaz Atschekzei, Paul Siek, Torsten Witte

Clin Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macular Microvasculature Is Different in Patients with Primary Sjögren's Disease Compared to Healthy Controls.
Gyde Tadsen, Nadine Zehrfeld, Laura Hoffmann, Marten Gehlhaar, Bettina Hohberger, Torsten Witte

Diagnostics (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritis.
Franz Felix Konen, Torsten Witte, Diana Ernst, David Hagin, Konstantin Fritz Jendretzky

Neurol Res Pract· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No difference in endothelial microvasculation measured by peripheral arterial tonometry in patients with Sjögren's disease and matched controls.
Franziska Maria Tapken, Nadine Zehrfeld, Malin Abelmann, Anna Charlotte Müller-Vahl, Sabrina Benz, Torsten Witte

Front Med (Lausanne)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel autoantibodies in Sjögren's disease.
Fiona Engelke, Petra Budde, Salvatore De Vita, Thomas Dörner, Diana Ernst, Torsten Witte

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reappraisal of IgG subclass deficiencies: a retrospective comparative cohort study.
Damla Dogru, Yagmur Dogru, Faranaz Atschekzei, Abdulwahab Elsayed, Natalia Dubrowinskaja, Torsten Witte

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Premature Ischemic Stroke in Sjögren's Disease.
Sonja Beider, Nadine Zehrfeld, Franziska Maria Tapken, Fiona Engelke, Tabea Seeliger, Torsten Witte

J Stroke· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD74 autoantibodies in axial spondyloarthritis as biomarkers for activity and severity of disease but not for tumour necrosis factor inhibitor retention: data from the Swiss Clinical Quality Management in rheumatic diseases cohort.
Annik Steimer, Andrea Götschi, Torsten Witte, Almut Scherer, Jonas Brändli

Clin Rheumatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis - a retrospective analysis from the RHADAR database.
Linus Maximilian Risser, Torsten Witte, Matthias Englbrecht, Patrick-Pascal Strunz, Matthias Froehlich

Rheumatol Int· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis